Log in to save activitiesYour saved activities will show here so that you can easily access them whenever you're ready. Log in hereCME & EducationLog in to keep track of your credits.
Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Emerging CKD in T2D Treatments: Focus on SafetyCME / ABIM MOCIn this CME-TV episode, Peter Rossing shares his insights on new developments and data on the safety of nonsteroidal MRAs for CKD in T2D.
Medscape Education Diabetes & Endocrinology, August 2021
MOA Comparison: Traditional vs New/Emerging MRAsCME / ABIM MOCRajiv Agarwal, MD, and Susan Mayor, review the history of mineralocorticoid-receptor antagonists including new/emerging nonsteroidal MRAs.
Medscape Education Diabetes & Endocrinology, June 2021
What Are the Risks of Over-the-Counter Memory Supplements? CME / ABIM MOC / CEThis article is intended for primary care physicians, neurologists, nurses, pharmacists, and other clinicians who treat and manage individuals who receive supplements to enhance cognitive function.
Medscape Education Neurology & Neurosurgery, March 2020
Treating Low Testosterone in Men: A Clinical UpdateCME / ABIM MOC / CENew recommendations suggest that testosterone therapy should only be used for sexual dysfunction among men with age-related low testosterone.
Medscape Education Clinical Briefs, February 2020
Are Concussion and Low Testosterone Related? CME / ABIM MOC / CEConcussions among former football players are associated with higher rates of erectile dysfunction and low testosterone in a new study.
Erectile dysfunction, formerly called male impotence, is the persistent inability to achieve or maintain an adequate erection. The causes of erectile dysfunction can be organic or psychogenic. Erectile dysfunction treatment was revolutionized with the introduction of the erectile dysfunction medication sildenafil and several similar erectile dysfunction drugs that followed, including vardenafil and tadalafil, which were approved for first-line treatment of erectile dysfunction.
